Reducing Arrhythmia in Dialysis by Adjusting the Rx Electrolytes/Ultrafiltration, Study B

Exclusion Criteria

• •Expected survival \<6 months-to allow trial completion
• •Renal transplant, transfer to home or peritoneal dialysis, or to non-study hemodialysis facility anticipated within 6 months
• •Prisoners or cognitive disability preventing informed consent
• •Pregnancy. A pregnancy test will be required for women of child bearing potential prior to enrollment. A pregnancy test will not be required for women past the age of child-bearing potential \>55 years old, women with a history of surgical sterilization, or for women \<55 years of age who have not had a menses within the past 12 months
• •Skin condition, immune dysfunction, history of multiple infections or other condition which increases risk of local infection with ILR placement
• •Bleeding disorder or anti-coagulation that cannot be reversed for ILR placement
• •Existing pacemaker, implantable monitor or defibrillator which precludes device placement
• •Chronic, persistent AF (defined as the presence of persistent AF on all available EKGs at time of recent screening)